Fracture and Bone Mineral Density Response by Baseline Risk...

  • Main
  • 2019 / 08
  • Fracture and Bone Mineral Density Response by Baseline Risk...

Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend Trial

Leder, Benjamin, Zapalowski, Carol, Hu, Ming‐yi, Hattersley, Gary, Lane, Nancy E., Singer, Andrea J., Dore, Robin K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Bone and Mineral Research
DOI:
10.1002/jbmr.3848
Date:
August, 2019
File:
PDF, 1.39 MB
english, 2019
Conversion to is in progress
Conversion to is failed